Teradyne (TER) Cash & Equivalents (2009 - 2026)

Teradyne has reported Cash & Equivalents for 18 years, with the latest figure at $349.5 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $349.5 million, up 3.03% year-over-year; the trailing twelve-month figure through Jun 2026 was $349.5 million (up 3.03% YoY), and the FY2025 annual result was $293.8 million, down 46.91% from the prior year.
• Cash & Equivalents improved to $349.5 million in Q2 2026, from $241.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $854.8 million in Q4 2022 and troughed at $241.9 million in Q1 2026.
• A 5-year average of $541.9 million and a median of $562.7 million in 2022 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2024, when Cash & Equivalents rose 8.96%; it then tumbled 49.13% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $854.8 million in 2022, then fell by 11.37% to $757.6 million in 2023, then retreated by 26.96% to $553.4 million in 2024, then sank by 46.91% to $293.8 million in 2025, then increased by 18.99% to $349.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $349.5 million in Q2 2026, $241.9 million in Q1 2026, and $293.8 million in Q4 2025.